Evidence map›Paper›PMID 37692209›Full record

ArticleACS omega2023

Cationic Chitosan Derivatives for the Inactivation of HIV-1 and SARS-CoV-2 Enveloped Viruses.

Zamani E D Cele, William Matshe, Lindani Mdlalose, Katlego Setshedi, Kanyane Malatji, Nompumelelo Prudence Mkhwanazi, Thandokuhle Ntombela, Mohammed Balogun

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Zamani E D CeleBio-Polymer Modification and Advanced Therapeutics Laboratory, Centre for Nanostructures and Advanced Materials, Council for Scientific and Industrial Research, Pretoria, Gauteng 0001, South Africa.ORCID https://orcid.org/0000-0001-7899-0719
William MatsheBio-Polymer Modification and Advanced Therapeutics Laboratory, Centre for Nanostructures and Advanced Materials, Council for Scientific and Industrial Research, Pretoria, Gauteng 0001, South Africa.
Lindani MdlaloseBio-Polymer Modification and Advanced Therapeutics Laboratory, Centre for Nanostructures and Advanced Materials, Council for Scientific and Industrial Research, Pretoria, Gauteng 0001, South Africa.
Katlego SetshediBio-Polymer Modification and Advanced Therapeutics Laboratory, Centre for Nanostructures and Advanced Materials, Council for Scientific and Industrial Research, Pretoria, Gauteng 0001, South Africa.
Kanyane MalatjiEmerging Research Area Platform, Next Generation Health Cluster, Council for Scientific and Industrial Research, Pretoria, Gauteng 0001, South Africa.
Nompumelelo Prudence MkhwanaziCollege of Health Science, School of Laboratory Medicine and Medical Science, HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, KwaZulu-Natal 4041 South Africa.
Thandokuhle NtombelaFaculty of Science, School of Chemistry, University of the Witwatersrand, Johannesburg 00000, South Africa.
Mohammed BalogunBio-Polymer Modification and Advanced Therapeutics Laboratory, Centre for Nanostructures and Advanced Materials, Council for Scientific and Industrial Research, Pretoria, Gauteng 0001, South Africa.
Council for Scientific and Industrial Research · ZAUniversity of KwaZulu-Natal · ZAUniversity of the Witwatersrand · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cationic chitosan derivatives have been widely studied as potential antimicrobial agents. However, very little is known about their antiviral activity and mode of action against enveloped viruses. We investigated the ability of hydroxypropanoic acid-grafted chitosan (HPA-CS) and

Identifiers

PMID37692209
PMCPMC10483524
OpenAlexW4386127325

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.